First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer
| Autor: | Masi, G. *, Marcucci, L., Loupakis, F., Cerri, E., Barbara, C., Bursi, S., Allegrini, G., Brunetti, I.M., Murr, R., Ricci, S., Cupini, S., Andreuccetti, M., Falcone, A. |
|---|---|
| Zdroj: | In Annals of Oncology August 2006 17(8):1249-1254 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|